CRT 2016 Coronary - Antiplatelet Responsiveness, Genetics, Genomics and Drug-to-Drug Interactions: The Great Debate

Conference
Session on Antiplatelet Responsiveness, Genetics, Genomics and Drug-to-Drug Interactions: The Great Debate at CRT 2016

Add this Moment to your Passport

Learn from this moment and keep it forever.
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Overview


CRT 2016 Coronary - Antiplatelet Responsiveness, Genetics, Genomics and Drug-to-Drug Interactions: The Great Debate

Session Moderators & Panelists: Dominick Angiolillo, MD, PhD, FSCAI; C. Michael Gibson, MD; Neal Kleiman, MD, FSCAI; Michael Gaglia, MD, MSc, FSCAI

2 Expert Sessions

Featuring

  • Dominick Angiolillo, MD, PhD, FSCAI
  • C. Michael Gibson, MD
  • Neal Kleiman, MD, FSCAI;
  • Michael Gaglia, MD, MSc, FSCAI
  • Paul Gurbel, MD, FSCAI
  • Alexandra Lansky, MD, FSCAI
  • Jeffrey Berger, MD, MS
  • Michael Lipinski, MD, PhD, FSCAI

Add this Moment to your Passport

Learn from this moment and keep it forever.
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.



Target Audience

  • Interventional Cardiologists
  • Interventional Fellows

Session Name: Antiplatelet Responsiveness, Genetics, Genomics and Drug-to-Drug Interactions: The Great Debate

Track: Coronary

Learning Objectives

  • Update in advances in ACS & AMI Management

Loading Simple Education